Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156854 · ClinicalTrials.gov registry record · NA
Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04156854: Completed NA study, sponsored by Mayo Clinic.
NCT04156854 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04156854, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Researchers are trying learn more about how the heart and blood volume interact in subjects with heart failure and how measuring blood volume may help them develop better ways of treating and managing heart failure patients.
Interventions
- DIAGNOSTIC_TEST Quantitated Blood Volume Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2022-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156854
The ClinicalTrials.gov registry entry for NCT04156854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantitated Blood Volume Analysis is the first listed.
NCT04156854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04156854 about?
NCT04156854 is a clinical study titled "Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure". Researchers are trying learn more about how the heart and blood volume interact in subjects with heart failure and how measuring blood volume may help them develop better ways of treating and managing heart failure patients.
What is the current status of trial NCT04156854?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-01-30. Estimated completion is 2022-12-19.
What interventions are being tested in trial NCT04156854?
The interventions under investigation include: Quantitated Blood Volume Analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04156854?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.